Related Experiment Video
Updated: Jul 27, 2025
07:30
Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion
Published on: May 10, 2018
9.3K
Rab26 restricts insulin secretion via sequestering Synaptotagmin-1.
Ruijuan Zhuang1, Yuxia Zhou2, Ziyan Wang1
1School of Pharmaceutical Sciences, State Key Laboratory of Cellular Stress Biology, Fujian Provincial Key Laboratory of Innovative Drug Target Research, Xiamen University, Fujian, China.
Plos Biology
|June 8, 2023
Summary
Rab26 negatively regulates insulin secretion by pancreatic beta cells. Its absence increases insulin release, while its presence inhibits it by interfering with granule fusion.
Area of Science:
- Cell Biology
- Endocrinology
- Molecular Biology
Background:
- Rab26's function in pancreatic beta cell insulin secretion is not well understood.
- Rab26 was initially identified in the pancreas, suggesting a potential role in its function.
Purpose of the Study:
- To investigate the role of Rab26 in regulating insulin secretion from pancreatic beta cells.
- To elucidate the molecular mechanism by which Rab26 affects insulin exocytosis.
Main Methods:
- Generation of Rab26 knockout (Rab26-/-) mice using CRISPR/Cas9.
- Rab26 knockdown in pancreatic insulinoma cells.
- Overexpression of Rab26 in insulinoma cells and isolated mouse islets.
- Immunofluorescence microscopy, GST-pulldown assays, and Total Internal Reflection Fluorescence (TIRF) microscopy.
Main Results:
- Rab26 deficiency led to increased blood insulin levels upon glucose stimulation in mice.
- Rab26 knockdown promoted insulin secretion, while overexpression suppressed it in cell lines and islets.
- Overexpression of Rab26 caused insulin granule clustering and inhibited exocytosis by sequestering Syt1.
- Rab26 directly binds to Syt1's C2A domain, disrupting Syt1-SNAP25 interaction.
Conclusions:
- Rab26 acts as a negative regulator of insulin secretion in pancreatic beta cells.
- Rab26 inhibits insulin granule exocytosis by preventing fusion with the plasma membrane through Syt1 sequestration.
- Rab26's role in regulating insulin secretion has implications for understanding diabetes pathophysiology.
More Related Videos
Related Concept Videos
01:05Insulin Secretory Vesicles
5.0K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
5.0K
01:28Insulin: The Receptor and Signaling Pathways
1.3K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.3K
01:33Overview of Secretory Vesicles
8.6K
Secretory vesicles, also known as dense core vesicles (DCVs), are membrane-bound vesicles that transport secretory proteins, such as hormones or neurotransmitters. Regulated secretory vesicles transport proteins from the trans-Golgi network to the exterior of the cell. Proteins present in regulated secretory vesicles are required to be rapidly exocytosed in large amounts upon a specific stimulus.
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
8.6K
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.3K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.3K
01:24Glucagon-like Receptor Agonists
370
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
370
01:45Tail-anchoring of Proteins in the ER Membrane
3.1K
Tail-anchored, or TA, proteins are estimated to make up to 3-5% of membrane proteins found in the eukaryotic cell. Such proteins have a single transmembrane domain located approximately 30 amino acid residues upstream from the C-terminal end. As a result, the signal recognition particle (SRP) cannot guide a TA protein to the ER membrane for cotranslational insertion. Hence, they are integrated into the ER membrane post-translationally using their C-terminal end as the anchor. TA proteins...
3.1K